Skip to main content
Skip to primary sidebar

The Chandler Project

Home
About
News
Events
Contact

Blog

Primary Sidebar

The Chandler Project

The Chandler Project is a patient-focused organization that provides those affected by achondroplasia + other forms of dwarfism & skeletal dysplasia with the latest in pharmaceutical research and surgical advancements.
🦋 🦋 🦋

Achondroplasia Research News

Follow on Instagram

The @chandlerproject has been nominated for a @globalgenes 2021 RARE Champions of #Hope award for RARE Champion in #Advocacy, Foundation! 🎉

via Multidisciplinary Digital Publishing Institute (MDPI) ･ August 30, 2021 – Simultaneous Bilateral Femoral and Tibial Lengthening in #Achondroplasia

What do naan, focaccia, croissants, and pretzels have in common? Other than making one’s mouth water 😋 they also provide a unique learning opportunity!

TODAY – August 27, 2021 – European Commission Approves #BioMarin’s #VOXZOGO® (#vosoritide) for the Treatment of Children with #Achondroplasia from Age 2 Until Growth Plates Close

Recent Posts

European Commission Approves BioMarin’s VOXZOGO® (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Vosoritide in Europe: will payers cover BioMarin’s dwarfism drug?
BioMarin gears up for two ‘transformational’ launches, Voxzogo and Roctavian: CEO
Rarities With Anesthetic Implications: Lupus, Pemphigus, Achondroplasia
2021 Achondroplasia Research Conference Survey

Categories

Achondroplasia
Ascendis
BioMarin
Health & Wellness
Hypochondroplasia
Limb Lengthening
Pfizer
QED
Skeletal Dysplasia
Therachon

Archives

Archives

Copyright © 2021 · The Chandler Project, Inc. · Tax ID: 83-1692863

search

type + hit enter